Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Botulinum toxin is not effective for treating androgenetic alopecia.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

A new microneedle system effectively delivers finasteride to treat hair loss.

Ethosomal carriers effectively deliver hair loss drug into skin.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

A microneedle patch system was developed for quick, convenient, and efficient delivery of hair loss treatment drug, Finasteride.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

A new liposomal system for applying dutasteride to the skin was developed, showing better skin absorption and stability, potentially improving treatment for hair loss.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Dissolving microneedles with finasteride improve drug delivery for hair loss treatment.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.